Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  John Wiley & Sons Inc    JW.A

JOHN WILEY & SONS INC (JW.A)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/22 08:55:03 pm
65.7 USD   -0.68%
2017 JOHN WILEY & SO : ex-dividend day
2017 JOHN WILEY & SO : posts 2Q profit
2017JOHN WILEY & SO : half-yearly earnings release
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/16/2018 01/17/2018 01/18/2018 01/19/2018 01/22/2018 Date
65.15(c) 65.1(c) 65.8(c) 66.15(c) 65.7 Last
261 874 169 104 194 702 186 275 96 001 Volume
-0.08% -0.08% +1.08% +0.53% -0.68% Change
More quotes
Financials ($)
Sales 2018 1 759 M
EBIT 2018 245 M
Net income 2018 163 M
Debt 2018 -
Yield 2018 1,93%
Sales 2019 1 770 M
EBIT 2019 269 M
Net income 2019 201 M
Debt 2019 -
Yield 2019 2,03%
P/E ratio 2018 23,25
P/E ratio 2019 18,40
Capi. / Sales2018 2,14x
Capi. / Sales2019 2,12x
Capitalization 3 760 M
More Financials
Company
John Wiley & Sons, Inc.is a research company.It operates through the following segments: Research, Publishing and Solutions.The Research segment serves the world's research and scholarly communities and is the publisher for professional and scholarly societies.Its products include scientific,... 
More about the company
Surperformance© ratings of John Wiley & Sons Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on JOHN WILEY & SONS INC
2017 JOHN WILEY & SONS INC : ex-dividend day
2017 JOHN WILEY & SONS : posts 2Q profit
2017JOHN WILEY & SONS INC : half-yearly earnings release
2017 JOHN WILEY & SONS INC : ex-dividend day
2017 JOHN WILEY & SONS : Better Rechargeable Batteries Coming Soon? Hybrid indium-lit..
2017 JOHN WILEY & SONS : Pelvic Floor Society Issues Statement on the Use of Mesh in ..
2017 JOHN WILEY & SONS : Obesity May Adversely Affect Sperm Quality
2017 JOHN WILEY & SONS : Asthma Medication May Have Psychiatric Side Effects
2017 JOHN WILEY & SONS : Certain Bone Deficits May Increase Fracture Risk in Individu..
2017 JOHN WILEY & SONS : Radavirsen Performs Well in Early Influenza Trial
More news
Sector news : Professional Information Services - NEC
01/18 European Corporate Roundup for Thursday
01/18 European Corporate Roundup for Thursday
01/18 EXPERIAN : 3Q Organic Revenue Rose 5%, Maintains 2018 Expectations
01/11 MOODY : European watchdog warns credit rating agencies over fees
01/04 IHS MARKIT : Service Sector Expansion Slows in December -- IHS Markit
More sector news : Professional Information Services - NEC
Latest Tweets
01/19The VP, Treasurer of John Wiley Sons Cl A (NYSE: JW.A) is Selling Shares  
01/05Want automatic email alerts for $JW.A $RXII $AQ $GHL $JMBA? Subscribe to Mark.. 
01/03TREND REVERSAL DOWN ALERT: $JW.A JOHN WILEY & SONS ? TradeIdeas via  
2017John Wiley & Sons Inc $JW.A Given Consensus Recommendation of “Hold” by A.. 
2017Get the latest ratings for $IR $JRJC $CNS $JW.A $RXII in your inbox with Mark.. 
More tweets
Qtime:61
News from SeekingAlpha
2017 John Wiley & Sons declares $0.32 dividend
2017 John Wiley and Sons announces partnership with Arizona State University
2017 John Wiley & Sons, Inc. 2018 Q2 - Results - Earnings Call Slides
2017 John Wiley & Sons' (JW.A) CEO Matthew Kissner on Q2 2018 Results - Earnings C..
2017 Wiley at 2.5-year highs after earnings beat
Chart JOHN WILEY & SONS INC
Duration : Period :
John Wiley & Sons Inc Technical Analysis Chart | JW.A | US9682232064 | 4-Traders
Technical analysis trends JOHN WILEY & SONS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 63,7 $
Spread / Average Target -3,8%
EPS Revisions
Managers
NameTitle
Brian A. Napack President & Chief Executive Officer
Matthew S. Kissner Chairman
John A. Kritzmacher CFO, Executive VP-Technology & Operations
Judy K. Verses Executive Vice President-Research
William B. Plummer Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS INC0.61%3 760
RELX-5.69%47 173
RELX N.V.-4.88%47 154
S&P GLOBAL INC4.36%46 191
THOMSON REUTERS CORP-0.40%31 003
EQUIFAX4.49%14 953